Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis

Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis

Abstract Background A decade ago, statin persistence was < 50% after 1 year, and recent short-term analyses have revealed very little progress in improving statin persistence, even in patients with a prior cardiovascular (CV) event. Data on longer-term statin persistence are lacking. We measured...

Full description

Bibliographic Details
Main Authors: Peter P. Toth, Craig Granowitz, Michael Hull, Amy Anderson, Sephy Philip
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Lipids in Health and Disease
Subjects:
Statin
Triglycerides
Persistence
Discontinuation
Atherosclerotic cardiovascular disease
Diabetes
Online Access:http://link.springer.com/article/10.1186/s12944-019-1099-z

Internet

http://link.springer.com/article/10.1186/s12944-019-1099-z

Similar Items